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ABSTRACT Legionella pneumophila, the etiological agent of legionellosis, replicates within phagocytic cells. Crucial to biogene-
sis of the replicative vacuole is the Dot/Icm type 4 secretion system, which translocates a large number of effectors into the host
cell cytosol. Among them is LegK2, a protein kinase that plays a key role in Legionella infection. Here, we identified the actin nu-
cleator ARP2/3 complex as a target of LegK2. LegK2 phosphorylates the ARPC1B and ARP3 subunits of the ARP2/3 complex.
LegK2-dependent ARP2/3 phosphorylation triggers global actin cytoskeleton remodeling in cells, and it impairs actin tail forma-
tion by Listeria monocytogenes, a well-known ARP2/3-dependent process. During infection, LegK2 is addressed to the
Legionella-containing vacuole surface and inhibits actin polymerization on the phagosome, as revealed by legK2 gene inactiva-
tion. Consequently, LegK2 prevents late endosome/lysosome association with the phagosome and finally contributes to remodel-
ing of the bacterium-containing phagosome into a replicative niche. The inhibition of actin polymerization by LegK2 and its
effect on endosome trafficking are ARP2/3 dependent since it can be phenocopied by a specific chemical inhibitor of the ARP2/3
complex. Thus, LegK2-ARP2/3 interplay highlights an original mechanism of bacterial virulence with an unexpected role in local
actin remodeling that allows bacteria to control vesicle trafficking in order to escape host defenses.
IMPORTANCE Deciphering the individual contribution of each Dot/Icm type 4 secretion system substrate to the intracellular
life-style of L. pneumophila remains the principal challenge in understanding the molecular basis of Legionella virulence. Our
finding that LegK2 is a Dot/Icm effector that inhibits actin polymerization on the Legionella-containing vacuole importantly
contributes to the deciphering of the molecular mechanisms evolved by Legionella to counteract the endocytic pathway. Indeed,
our results highlight the essential role of LegK2 in preventing late endosomes from fusing with the phagosome. More generally,
this work is the first demonstration of local actin remodeling as a mechanism used by bacteria to control organelle trafficking.
Further, by characterizing the role of the bacterial protein kinase LegK2, we reinforce the concept that posttranslational modifi-
cations are key strategies used by pathogens to evade host cell defenses.
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Legionella pneumophila is the most common etiological agent ofsevere legionellosis pneumonia in humans. Pathogenic Legio-
nella strains emerge in the environment after intracellular multi-
plication in amoebae. Bacteria are disseminated by water aerosols
and, when inhaled into the lungs, engulfed by alveolar macro-
phages. Within environmental phagocytic cells and human mac-
rophages, a functional Dot/Icm type 4 secretion system (T4SS)
and the approximately 300 proteins it secretes (1) are absolutely
required for Legionella to reroute its phagosome and trigger the
biogenesis of a Legionella-containing vacuole (LCV), a rough en-
doplasmic reticulum-like compartment permissive for its intra-
cellular replication (2–4). Recently, important investigative ef-
forts have begun to decipher the individual contributions of
protein effectors to the Legionella intracellular life-style. Most of
this work has relied on the construction of deletion mutants for
the corresponding T4SS substrates. However, because of func-
tional redundancy between effectors, single gene deletions very
rarely result in a virulence defect; consequently, to date, only a few
T4SS effectors have been functionally characterized (for reviews,
see references 5 to 9). Among these are proteins that interfere with
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small GTPases of the early secretory cellular pathway (10–17), the
endocytic pathway (18), or the retrograde vesicle trafficking (19)
or target the innate immune response and host cell apoptosis
pathways (7, 20,21).
Many Dot/Icm-secreted effectors display distinctive eukary-
otic domains that include protein kinase domains (22, 23). In silico
analysis of effector sequences and in vitro phosphorylation assays
with purified proteins identified five functional protein kinases,
designated LegK1 to -5, that are encoded by the epidemic L. pneu-
mophila Lens strain (24). All of the Legionella protein kinases ex-
cept LegK5 are Dot/Icm effectors. Of these kinases, LegK1 has
been shown to induce activation of the NF-B transcription factor
and, consequently, genes with antiapoptotic functions (25). In
vitro and cell-free reconstitution assays have shown that LegK1
phosphorylates the NF-B inhibitor IB. However, it is notewor-
thy that despite the role of LegK1 in activating the NF-B pathway,
a legK1 deletion mutant does not present a virulence defect. In
contrast to LegK1, we previously reported that inactivation of the
legK2 gene resulted in a significant decrease in L. pneumophila
virulence toward amoeba and macrophages, highlighting the key
role of this effector in Legionella virulence. More precisely, the
legK2 mutant poorly evades endocytic degradation and results in
delayed intracellular replication. Because a kinase-dead legK2
mutant exhibits the same virulence defects as the deletion mutant,
we concluded that the protein kinase activity of LegK2 is directly
involved in evading host cell defenses and in the establishment of
a replicative niche (24).
Here, we aimed to determine the precise function of LegK2-
dependent protein phosphorylation during L. pneumophila infec-
tion. We show that LegK2 interacts with the ARPC1B and ARP3
subunits of the actin nucleator ARP2/3 complex. We demonstrate
that LegK2 phosphorylates these subunits in vitro and in cells.
Finally, we establish that the LegK2-ARP2/3 interplay inhibits ac-
tin polymerization on the LCV and interferes with late endosome/
lysosome trafficking toward the LCV. Thus, we show for the first
time that host cell actin remodeling is essential for Legionella to
perturb host cell endocytic vesicle trafficking and allow bacteria to
escape cell defenses.
RESULTS
LegK2 specifically interacts with host cell ARP2/3 complex sub-
units. To identify host cell proteins that interact with LegK2, we
performed yeast two-hybrid screening. The construct pGBKT7-
legK2, which encodes LegK2 fused to the DNA binding domain of
GAL4 (GAL4BD-LegK2), was transformed into Saccharomyces
cerevisiae strain AH109. The toxicity/self-activation of this con-
struct was evaluated by mating yeast strain AH109(pGBKT7-
legK2) and reporting yeast strain Y187 for histidine auxotrophy,
transformed by the empty vector pACT2. While no toxicity was
detected, as indicated by the growth of the diploid (Fig. 1A, SD-
W-L, lane 6), self-activation was observed. Therefore, we made
use of a competitive inhibitor of the reporter HIS3 gene product
3-aminotriazole (3AT). When AH109(pGBKT7-legK2) was
grown in the presence of 3AT, self-activation was decreased but
not completely abolished (Fig. 1A, SD-W-L-H3AT, lane 6). The
Y187 yeast strain transformed by a human normalized cDNA
spleen library cloned into pACT2 was mated with AH109-
(pGBKT7-legK2), and diploids were screened for histidine auxot-
rophy in the presence of 10 mM 3AT. DNA sequences fused to the
transcription-activating domain of GAL4 in vector pACT2 in the
selected clones were amplified by PCR and sequenced. Reproduc-
ibly, several candidates for interaction with LegK2 were proteins
involved in actin cytoskeleton assembly. Because the legK2 mu-
tant phenotype alters host cell vesicle trafficking during infection,
particular attention was given to proteins of this family, which
included ARP3 and ARPC1B subunits of the actin filament nucle-
ator ARP2/3 complex.
To confirm that ARP3 and ARPC1B interact with LegK2, cD-
NAs from each of these two genes, named ACTR3 and ARPC1B,
respectively, were cloned into vector pACT2 and transformed into
reporting yeast strain Y187. Y187(pACT2-ACTR3) and Y187-
(pACT2-ARPC1B) were mated with AH109(pGBKT7-legK2),
and diploids were assayed for histidine auxotrophy in the presence
of 10 mM 3AT. Both diploids were able to grow without histidine
(Fig. 1A, SD-W-L-H3AT, lanes 2 and 4), which confirms the
interactions between LegK2 and ARP3 and ARPC1B subunits. To
determine if the interactions between LegK2 and ARP3 or
ARPC1B subunits are specific, similar binary yeast two-hybrid
assays were performed with LegK1 from L. pneumophila, which is
known to subvert the host cell NF-B pathway independently of
ARP3/ARPC1B subunits. The AH109(pGBKT7-legK1) strain was
constructed and then mated with Y187(pACT2-ACTR3) and
Y187(pACT2-ARPC1B). Diploids could not grow without histi-
dine (Fig. 1A, SD-W-L-H3AT, lanes 1 and 3), which indicates
that LegK1 does not interact with these ARP2/3 complex subunits.
Together, these results strongly suggest that LegK2 interactions
with ARP3 and ARPC1B subunits are specific.
Next, we investigated interactions between LegK2 and ARP3/
ARPC1B subunits in mammalian cells by affinity copurification.
Vectors pDEST27-legK2 and pCI-Neo3Flag-ACTR3 or -ARPC1B
were constructed to express N-terminally glutathione S-trans-
ferase (GST)-tagged LegK2 and N-terminally Flag-tagged ARP3
or ARPC1B, respectively, in mammalian cells. HEK293T cells
were cotransfected with these vectors, and GST-LegK2 was puri-
fied with a glutathione-agarose matrix. We found that GST-LegK2
(90 kDa) was expressed and detected 24 h posttransfection and
that Flag-tagged ARPC1B (45 kDa), but not Flag-tagged ARP3,
was copurified with the Legionella protein kinase (Fig. 1B). The
same experiment was performed with a vector expressing the
kinase-dead variant GST-LegK2K112M, where the invariant lysine
essential for donor-ATP binding is substituted. As expected,
ARPC1B was also copurified with this catalytic variant of LegK2.
As ARPC1B was not purified with GST, these data confirm that
LegK2 specifically interacts with the ARPC1B subunit of the
ARP2/3 complex in mammalian cells. Regarding ARP3, we pro-
pose that the interaction between LegK2 and ARP3 is too weak
and/or transient to be detected by affinity copurification under
our conditions.
The subcellular localization of the bacterial protein kinase
LegK2 and ARP2/3 subunits was analyzed after transfection into
HEK293T cells. pDEST27-legK2- or -legK1- and pCI-Neo3Flag-
ACTR3- or -ARPC1B-cotransfected fibroblasts were stained with
anti-GST and anti-Flag antibodies to detect GST-LegK2/LegK1
and Flag-ARP3/ARPC1B, respectively (Fig. 1C). Both antibodies
labeled the cytoplasm and periphery of cells with similar staining
patterns when cells were cotransfected with pDEST27-legK2 and
pCI-Neo3Flag-ACTR3 or -ARPC1B, while anti-GST labeling in
cells cotransfected with the empty vector or the LegK1 expressing
vector was diffused in the cell. These observations suggest that
LegK2 specifically colocalizes with ARPC1B and ARP3. To quan-
Michard et al.
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tify the degree of colocalization of GST-tagged LegK2 and Flag-
tagged ARP3/ARPC1B, we calculated the Pearson overlap coeffi-
cient for each antibody. Pearson coefficients of 0.87 for both
ARPC1B and ARP3 support colocalization with LegK2 and are
consistent with a physiological relevance of the interactions be-
tween LegK2 and the ARP2/3 complex subunits in mammalian
cells (Fig. 1D).
Bacterial protein kinase LegK2 phosphorylates ARP3 and
ARPC1B subunits. Because LegK2 specifically interacts with
ARP3 and ARPC1B subunits and as ARP3 and ARPC1B had been
previously described to be phosphorylated on threonine residues
in mammalian cells (26–28), we investigated whether either pro-
tein is a substrate of the bacterial protein kinase LegK2. The
ARP2/3 complex was purified from the amoeba Acanthamoeba
castellanii (Fig. 2A, lanes 1 and 6) and dephosphorylated by the
dual-specificity Antarctic phosphatase (Fig. 2A, lanes 2 and 7).
The dephosphorylated ARP2/3 complex was then incubated in the
presence of ATP with purified recombinant GST-LegK2 or its
kinase-dead variant GST-LegK2K112M. Proteins were separated by
SDS-PAGE and probed with antiphosphothreonine antibodies.
FIG 1 LegK2 interacts with ARPC1B and ARP3 subunits of the ARP2/3 complex. (A) Yeast two-hybrid assays of L. pneumophila protein kinase LegK1/LegK2
and ARPC1B/ARP3 subunits of the human ARP2/3 complex. Diploids from the mating of AH109(pGBKT7-legK1) or AH109(pGBKT7-legK2) with
Y187(pACT2), Y187(pACT2-ARPC1B), or Y187(pACT2-ACTR3) were grown on SD medium without tryptophan (W) or leucine (L). Histidine auxotrophy
was tested by plating 5 or 50 l of diploids on SD-W-L medium without histidine (H) in the presence of 10 mM 3-AT. (B) Affinity copurification of Flag-tagged
ARP2/3 subunits with GST-tagged LegK2 protein. HEK293T cells were cotransfected with pDEST27, pDEST27-legK2, or pDEST27-legK2K112M and pCI-
Neo3Flag-ARPC1B or -ACTR3. GST, GST-tagged LegK2, or LegK2K112M was purified on glutathione-agarose 4B, and purified fractions were immunoblotted
with both anti-GST and anti-Flag antibodies. (C) Cellular localization of ARPC1B/ARP3 and LegK2/LegK1 proteins in HEK293T cells cotransfected with
pDEST27, pDEST27-legK2, or -legK1 and pCI-Neo3Flag-ARPC1B or -ACTR3. The GST, GST-LegK2, and GST-LegK1 proteins were detected by immunoflu-
orescence with anti-GST antibodies (green), and 3Flag-ARPC1B and 3Flag-ARP3 were detected with anti-Flag antibodies (red). Scale bars, 10 m. (D)
Quantitation of colocalization by Pearson coefficient. The Pearson coefficient was determined with the JACoP plugin of the ImageJ software and is expressed as
the mean value calculated for 30 cells.
ARP2/3 Targeted by a Legionella Protein Kinase
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Western blot assays revealed that both ARP3 and ARPC1B were
phosphorylated in vitro by the catalytically active enzyme GST-
LegK2 (Fig. 2A, lanes 3 and 8), while no or weak phosphorylation
was observed with the kinase-dead mutant (Fig. 2A, lanes 4 and 9).
Antiphosphothreonine immunolabeling of ARP3 and ARPC1B
subunits decreased after incubation of the complex with Antarctic
phosphatase, thus demonstrating that ARP3 and ARPC1B were in
vitro modified by LegK2-catalyzed phosphorylation (Fig. 2A, lanes
5 and 10).
In order to confirm the physiological relevance of ARP2/3 sub-
unit phosphorylation, the ARP3 and ARPC1B phosphorylation
states were analyzed in mammalian cells ectopically expressing the
legK2 gene or the kinase-dead variant. HEK293T cells were
cotransfected with pDEST27-legK2 or -legK2K112M and pCI-
Neo3Flag-ACTR3 or -ARPC1B. The GST-tagged protein kinases
were well expressed at 24 h posttransfection, as revealed by immu-
noblot assays of whole-cell extracts with anti-GST antibodies
(Fig. 2B, lanes 3 and 4 and lanes 6 and 7). Flag-tagged ARP2/3
subunits were immunoprecipitated with anti-Flag antibodies and
then detected with anti-Flag or antiphosphothreonine antibodies.
In immunoblot assays, we found that the ARP3 and ARPC1B pro-
teins, well expressed and immunopurified in all of the samples,
appeared as two bands with close apparent molecular weights in
cells expressing LegK2 kinase (Fig. 2B, lanes 3 and 6). We next
examined whether these two bands represent two distinct phos-
phorylation states of ARP3 and ARPC1B. We found that in the
presence of LegK2, antibodies to phosphothreonine labeled ARP3
and ARPC1B (Fig. 2B, lanes 3 and 6). When cells were cotrans-
fected with the LegK2K112M-expressing vector, a single Flag-tagged
band was detected with anti-Flag antibodies while phosphorylated
forms of ARP3 and ARPC1B were not detected with antiphospho-
threonine antibodies (Fig. 2B, lanes 4 and 7). Thus, the bacterial
protein kinase LegK2 is able to phosphorylate ARP3 and ARPC1B
subunits of the ARP2/3 complex in mammalian cells.
LegK2 is an inhibitor of the ARP2/3 complex in vivo. The
effect of LegK2-dependent ARP2/3 phosphorylation on the actin
nucleation activity of the complex was first investigated by mea-
suring actin polymerization in vitro with the purified ARP2/3
complex and in mammalian cells. Proteins named nucleation-
promoting factors (NPFs) are recognized as the primary activators
of the ARP2/3 complex for actin nucleation. However, a recently
identified requirement for activation of nucleation is phosphory-
lation of ARP2/3 subunits, in particular, the ARPC1B and ARP2
subunits (26–28). We used pyrenyl actin assembly assays to mea-
sure actin polymerization in the presence of the purified dephos-
phorylated ARP2/3 complex and GST-LegK2. No significant in-
crease in actin polymerization was detected (see Fig. S1 in the
supplemental material). On the basis of this finding, we hypothe-
sized that LegK2 does not phosphorylate the sites of ARP2/3 sub-
units shown to activate the complex. To detect a putative inhibi-
tory effect of LegK2-dependent ARP2/3 phosphorylation on actin
nucleation, actin polymerization was then assessed in the presence
FIG 2 Protein kinase LegK2 phosphorylates ARPC1B and ARP3 subunits. (A) In vitro phosphorylation assays of ARPC1B and ARP3 subunits by LegK2 detected
by Western blot assay with antiphosphothreonine antibodies. The ARP2/3 complex purified from A. castellanii (lanes 1 and 6) and dephosphorylated (lanes 2 to
5 and 7 to 10) was incubated with purified GST-LegK2 (lanes 3, 5, and 8, 10) or its catalytic variant GST-LegK2K112M (lanes 4 and 9) in the presence of 100 M
ATP. Where indicated (lanes 5 and 10), ARP2/3 was further incubated with dual-specificity Antarctic phosphatase. ARP2/3 complex subunits were separated by
SDS-PAGE, stained with Coomassie blue, or detected with antiphosphothreonine antibodies. (B) In vivo phosphorylation assays of ARPC1B and ARP3 subunits
by LegK2. HEK293T cells were transfected with pCI-Neo3Flag-ARPC1B or -ACTR3 or cotransfected with pCI-Neo3Flag-ARPC1B or -ACTR3 and pDEST27-
legK2 or -legK2K112M. 3Flag-ARPC1B and 3Flag-ARP3 were immunoprecipitated with anti-Flag antibodies. Expression of GST-LegK2 and GST-LegK2K112M in
the total extract was checked by Western blot assay with anti-GST antibodies (lanes 3 and 4 and lanes 6 and 7). Immunoprecipitation (IP) of 3Flag-ARPC1B and
3Flag-ARP3 was checked by Western blot assay with anti-Flag antibodies (lanes 2 to 7). The phosphorylation level of 3Flag-ARPC1B and 3Flag-ARP3 was
detected with antiphosphothreonine antibodies. Protein bands have been cut to present samples in an order that matches our comments in the text.
Michard et al.
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of the purified endogenous phosphorylated ARP2/3 complex and
GST-LegK2. Our data showed that rates of actin nucleation and
polymerization were not modulated by LegK2 (see Fig. S1). Im-
portantly, mass spectrometry analysis of the in vitro phosphory-
lated ARP2/3 samples did not allow the detection of phosphory-
lated peptides; these data highlight that only a very small fraction
of the ARP2/3 complex was phosphorylated under these condi-
tions, which could explain the lack of in vitro effect of LegK2-
dependent ARP2/3 phosphorylation on actin ARP2/3 nucleation
activity.
To address whether actin nucleation could be controlled by
LegK2-dependent ARP2/3 phosphorylation in an in vivo context,
actin polymerization was analyzed in human epithelial HeLa cells
transfected with the empty vector peGFP or the peGFP-legK2 or
peGFP-legK2K112M vector, which encodes GFP and an
N-terminally GFP-fused LegK2 protein or its kinase-dead variant,
respectively. Transfected cells were analyzed by confocal micros-
copy for F-actin labeling. Three types of cell labeling were catego-
rized according to actin filament distribution: with long, straight
actin fibers that are contained within the body of the cell (type 1),
with reduced actin fibers that localize only at the periphery of the
cell (type 2), and without noticeable actin fibers (type 3) (Fig. 3A).
A total of 27.8% of the GFP-LegK2-expressing cells exhibited a
type 3 phenotype, which is more than the 11 and 12% of type 3
phenotype observed among cells transfected with the empty vec-
tor and the vector expressing kinase-dead variant GFP-
LegK2K112M, respectively (Fig. 3B). Thus, expression of active
LegK2 protein kinase in mammalian cells inhibits actin fiber po-
lymerization. Interestingly, expression of the kinase-dead variant
resulted in an intermediate phenotype of reduced actin fibers,
since cells transfected with the kinase-dead variant are character-
ized by a shift from type 1 to type 2, unlike empty-vector-
transfected cells (41.5% of the cells are type 2 for the catalytic
variant versus 20% for the empty vector). As previously proposed
for other protein kinases (29–32), it can be assumed that the in-
active form of LegK2 is still able to interact with ARP2/3 and that
overexpression of this inactive variant results in the titration of its
substrate, thus interfering with the cell actin cytoskeleton dy-
namic. Together, these data strongly support the notions that ex-
pression of LegK2 in mammalian cells inhibits the formation of
actin stress fibers and that the protein kinase activity of LegK2 is
partially responsible for this inhibition.
To establish whether LegK2 inhibits actin polymerization in an
ARP2/3-dependent manner, we monitored the effect of LegK2 on
two well-known ARP2/3-dependent processes, namely, cell inva-
sion and actin comet tail formation by Listeria. Mammalian cells
transfected with the empty peGFP vector or the peGFP-legK2 vec-
tor were infected with Listeria monocytogenes for 5 h. Actin was
labeled with fluorescent phalloidin, and cells were processed for a
differential immunolabeling protocol in which extracellular bac-
teria were differentiated from total ones (Fig. 3C). Cell transfec-
tion with peGFP does not hamper bacterial invasion, as reflected
by the low number of extracellular versus intracellular bacteria
(Fig. 3C, white versus blue channels). When quantified, only 2%
of the cells displayed extracellular bacteria (Fig. 3D). Actin comet
tail formation also takes place efficiently in GFP-expressing cells
(Fig. 3C, red channel), since less than 3% of the infected cells do
not exhibit these actin structures (Fig. 3E). In contrast, expression
of GFP-LegK2 increases the number of extracellular bacteria
(Fig. 3C, arrows) and reduces the number of intracellular ones
(Fig. 3C, arrowhead), resulting in about 18% of the cells display-
ing extracellular L. monocytogenes (Fig. 3D). Moreover, in 20%
of the infected GFP-LegK2-expressing cells, no actin comet tails
are detected (Fig. 3E). These effects depend on the protein kinase
activity of LegK2, since expression of the kinase-dead variant re-
sulted in only 3.8% of the cells displaying extracellular bacteria
(Fig. 3D) and 2.5% of the infected cells exhibiting no actin comet
tail (Fig. 3E), which is not significantly different from what is
observed in cells transfected with the empty vector peGFP. To-
gether, these results therefore indicate that ectopic expression of
active LegK2 protein kinase in mammalian cells inhibits ARP2/3-
dependent cell invasion and actin comet tail formation by
L. monocytogenes, leading to the conclusion that in cells, the pro-
tein kinase activity of LegK2 is an inhibitor of the actin nucleation
activity of the ARP2/3 complex.
LegK2 localizes to the LCV. To get insight into the role of
LegK2 during Legionella infection, we first analyzed the dynamics
of LegK2 localization in infected cells, i.e., after translocation into
the host cell cytosol. To examine LegK2 localization, the amoeba
Dictyostelium discoideum was infected with an L. pneumophila
legK2 mutant strain transformed with a vector encoding
N-terminally hemagglutinin (HA)-tagged LegK2. This strain does
not encode the endogenous LegK2 protein that might compete
with tagged LegK2 for translocation, localization, or function.
Bacteria were immunolabeled with an antibody directed against
the major outer membrane protein (MOMP) of L. pneumophila,
and HA-tagged LegK2 protein was revealed with an anti-HA an-
tibody at 0, 5, 10, 15, 20, 30, and 60 min after bacterium-amoeba
contact (Fig. 4A and B). As a control, D. discoideum amoebae were
also infected with the L. pneumophila dotA mutant strain trans-
formed with the same vector encoding HA-tagged LegK2. As ex-
pected, HA-tagged LegK2 protein was not detected when amoebae
were infected with the dotA mutant strain, confirming that LegK2
translocation is Dot/Icm dependent (Fig. 4A). In contrast, HA-
tagged LegK2 protein was found on the legK2 mutant strain LCVs
immediately after bacterial entry and with an increased frequency
up to 15 min postcontact before disappearance and was only
slightly detectable 20 min postcontact (Fig. 4B). This time-
dependent decrease may be due to rapid proteolytic degradation.
These results suggest that upon L. pneumophila infection, LegK2
function is very transient and localized mostly on LCVs. Because
the ARP2/3 complex was identified by proteomic analysis on the
nascent Legionella-containing phagosome (33–35), the transient
localization of LegK2 on the LCV supports a direct effect of LegK2
on ARP2/3 activity and consequently on actin polymerization on
the LCV.
LegK2 inhibits actin polymerization on the LCV. To address
the question of actin cytoskeleton remodeling during Legionella
infection, the amoeba D. discoideum was infected with the
mCherry-producing L. pneumophila Lens strain and the dotA and
legK2 deletion mutant strains and polymerized actin was visual-
ized with phalloidin-fluorescein isothiocyanate (FITC) at 15 min
postinfection (Fig. 4C). Infection with L. pneumophila does not
trigger significant cytoskeleton reorganization in host cells but
most likely induces local actin remodeling on the LCV. While less
than 2% of the wild-type (WT) bacterium-containing vacuoles
were labeled with phalloidin, more that 20% of the dotA mutant-
containing vacuoles were actin positive (Fig. 4D). Strikingly,
14.8% of the legK2 mutant-containing vacuoles were labeled with
phalloidin, a percentage that is significantly higher than that for
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WT LCVs (Fig. 4D). To confirm that this effect is due to the legK2
deletion, a legK2 gene-expressing vector was introduced into the
bacterium and found to complement the deletion. In comple-
mented cells, only 3.4% of the LCVs were phalloidin positive. In
contrast, the kinase-dead LegK2-expressing vector (plegK2cat)
did not complement the legK2 deletion since 13.8% of the LCVs
were phalloidin positive (Fig. 4D). Thus, LCVs containing an avir-
ulent mutant impaired for the T4SS, such as the dotA mutant or
the kinase-dead and legK2 deletion mutants, are decorated with
polymerized actin. It is noteworthy that neither WT nor dotA or
legK2 mutant LCVs are phalloidin positive when actin labeling is
performed immediately after uptake. This is consistent with pre-
vious observations that cortical actin associated with the bacterial
entry sites during phagocytosis disassemble from the Legionella-
containing phagosome less than 1 min after engulfment of the
bacteria (36). To further check that inhibition of actin polymer-
ization is correlated with the presence of LegK2 on the LCV,
D. discoideum amoebae were infected with an L. pneumophila
strain transformed with a vector encoding HA-tagged LegK2.
They were costained 15 min postinfection for LegK2 and actin
with anti-HA antibodies and phalloidin-FITC, respectively
(Fig. 4E). We observed that LegK2-positive vacuoles (red labeling)
were not labeled with phalloidin (green labeling), while LCVs that
did not exhibit LegK2 (blue labeling) were clearly actin positive
(Fig. 4E). When quantified on 50 LCVs from two independent
experiments, 100% of the LegK2-positive vacuoles lacked actin
labeling. Together, these data support the hypothesis that LegK2 is
translocated by the Dot/Icm T4SS into the host cell cytosol and its
protein kinase activity triggers local inhibition of actin polymer-
ization on the LCV after bacterial uptake.
LegK2 interferes with late endosome/lysosome trafficking to
the LCV. Actin-based intracellular movements of endosomes and
phagosomes are dependent on a driving force provided by the
ARP2/3 complex (37), and actin assembly on phagosome or late
endocytic organelles provides tracks for fusion partner organelles
to facilitate vesicle fusion (38). Taking into account (i) actin-
dependent endosome trafficking, (ii) the localization of LegK2
and its role in the inhibition of actin polymerization on the LCV,
and (iii) that a legK2 deletion mutant poorly evades endocytic
degradation since only 10% of mutated bacteria survive after cell
uptake (24), we hypothesized that LegK2 could be involved in the
control of phagosome maturation, in particular, by inhibiting the
fusion of the LCV with late endosomes.
D. discoideum was infected with the mCherry-labeled L. pneu-
mophila Lens strain or the dotA or legK2 deletion mutant, and the
late endosomal or lysosomal vacuolar H-ATPase (V-ATPase)
was labeled at 1 h postinfection by immunofluorescence with anti-
VatA antibodies (Fig. 5A). As a control, we observed that while the
WT Lens strain interferes with phagosome maturation, as dem-
onstrated by only 11.8% VatA-positive LCVs, a T4SS-impaired
dotA mutant strain is less able to inhibit the endocytic pathway
since around 45% of the dotA mutant-containing vacuoles are
labeled with VatA (Fig. 5B). About 28% of the legK2 mutant-
containing vacuoles were also VatA positive, which is significantly
higher than the 11.8% obtained in the case of WT LCVs. Trans-
forming the legK2 mutant with a WT LegK2-encoding vector par-
tially complements this endocytic pathway evasion defect by de-
creasing the percentage of VatA-positive vacuoles to 18.4% of the
LCVs. In contrast, the kinase-dead LegK2-expressing vector
(plegK2cat) did not complement the legK2 deletion since 33.9%
of the LCVs were VatA positive (Fig. 5B). Thus, the protein kinase
activity of LegK2 contributes to the blocking of late endosomal
trafficking toward the LCV and consequently allows bacteria to
escape the late endocytic pathway.
LegK2-ARP2/3 interplay controls actin polymerization on
the LCV to evade LCV-late endosome fusion. The data presented
above demonstrate that LegK2 interacts with and phosphorylates
two subunits of the actin filament nucleator ARP2/3, and it local-
izes to the LCV to inhibit both actin polymerization and late en-
dosome fusion with the LCV, thus contributing to escape of the
bacteria from the late endocytic pathway. In order to establish
whether these two major events controlled by LegK2 are related,
i.e., whether LegK2 inhibits ARP2/3 nucleation activity to control
actin polymerization on the LCV, D. discoideum was infected with
the mCherry-labeled legK2 mutant strain in the presence of
100 M CK-666, a specific inhibitor of the ARP2/3 complex
shown to block Listeria actin tail formation (39). Pharmacological
inhibition of ARP2/3 activity was preferred to ACTR3 and
ARPC1B silencing in order to temporally control ARP2/3 inhibi-
tion and consequently avoid a pleiotropic effect of this inhibition.
Infected cells were labeled with phalloidin, and vacuoles positive
for polymerized actin were scored (Fig. 6A). The presence of CK-
666 reverts the legK2 deletion mutant phenotype; i.e., it strongly
decreases the presence of actin on the LCVs so that the percentage
of actin-positive LCVs was similar to that obtained with WT
LCVs. Moreover, when infected cells were immunolabeled with
anti-VatA antibodies (Fig. 6B), addition of CK-666 resulted in a
significant decrease in VatA-positive vacuoles, suggesting that
FIG 3 LegK2 protein kinase activity inhibits actin polymerization in an ARP2/3-dependent manner. (A) Actin filament distribution in GFP-LegK2-expressing
HeLa cells. Polymerized actin was labeled with Alexa Fluor 594 phalloidin (red). Type 1 cells exhibit long and straight fibers in the body of the cell (arrow); type
2 is characterized by reduced and peripheral actin fibers (arrowhead); in type 3, neither central nor peripheral actin fibers are detected. Scale bars, 10 m. (B)
Quantitation of actin filament distribution in transfected HeLa cells. HeLa cells were transfected with the empty vector peGFP or vector peGFP-legK2 or
peGFP-legK2K112M. The actin network was evaluated in 40 cells transfected with each vector. These data are representative of three independent experiments, and
the error bars represent the standard deviations. (C) Cell invasion by Listeria and Listeria comet tail formation in GFP-LegK2-expressing mammalian cells. HeLa
cells transfected with the vector peGFP or peGFP-legK2 were infected for 5 h at an MOI of 5 with L. monocytogenes and then processed for differential
immunolabeling, in which extracellular bacteria were differentiated from total bacteria. Extracellular bacteria were labeled by a rabbit-derived polyclonal serum
(R11) and an Alexa Fluor 647-conjugated secondary antibody (white labeling); cells were then permeabilized, and total bacteria were labeled with the same R11
serum and an Alexa Fluor 350-coupled secondary antibody (blue labeling). Actin was labeled with Alexa Fluor 546 phalloidin (red labeling). In the right panel,
arrows indicate two extracellular bacteria, the dashed arrow highlights an intracellular bacterium with a short actin tail, and arrowheads point toward intracel-
lular bacteria without actin comet tails. Bar, 5 m. (D) Quantitation of cells with extracellular bacteria. peGFP-, peGFP-legK2-, or peGFP-legK2K112M-
transfected HeLa cells (100 for each transfection) with only extracellular bacteria were counted and compared to the total number of transfected cells with intra-
and extracellular bacteria. Results are expressed as the percentage of HeLa cells displaying only extracellular L. monocytogenes. These data are representative of
three independent experiments, and the error bars represent the standard deviations. (E) Quantitation of infected cells without actin comet tails. Cells were
processed as indicated for panel C, and the number of infected HeLa cells in which actin tails were not detectable was determined and expressed as a percentage
of the total. These data are representative of three independent experiments, and the error bars represent the standard deviations.
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FIG 4 LegK2 inhibits actin polymerization on the LCV. (A) HA-LegK2 detection on LCVs. D. discoideum was infected for 15 min at an MOI of 100 with
dotA or legK2 mutant L. pneumophila transformed with a vector encoding N-terminally HA-tagged LegK2. The presence of bacteria was detected by an
immunofluorescence assay with anti-MOMP antibodies (anti-Lp, red labeling), and the HA-LegK2 fusion is labeled with anti-HA antibodies (anti-HA,
green labeling). Scale bars, 5 m. (B) HA-LegK2 detection during LCV biogenesis. D. discoideum was infected at an MOI of 100 with legK2 mutant
L. pneumophila transformed with a vector encoding N-terminally HA-tagged LegK2. HA-LegK2-positive LCVs were counted at 0, 5, 10, 15, 20, 30, and 60
min after bacterium-amoeba contact (100 LCVs per time point). These data are representative of three independent experiments, and the error bars
represent the standard deviations. (C) Actin polymerization on LCVs during Legionella infection. D. discoideum was infected for 15 min at an MOI of 100
with mCherry-labeled legK2 mutant L. pneumophila. Polymerized actin on LCVs was detected by labeling with phalloidin-FITC. Arrows show examples
of actin-positive LCVs. Scale bar, 10 m. (D) Detection of polymerized actin in legK2 mutant-containing vacuoles. Actin-positive vacuoles (n  100)
were counted for amoeba infected with WT L. pneumophila strain Lens, the derivative dotA and legK2 mutants, and the transformed legK2(plegK2) and
legK2(plegK2cat) mutants. These data are representative of three independent experiments, and the error bars represent the standard deviations. **, P 
0.01. (E) Exclusive detection of LegK2 and actin on LCVs. D. discoideum was infected for 15 min at an MOI of 100 with L. pneumophila transformed with
a vector encoding HA-tagged LegK2. Bacteria were detected with anti-Lp1 serum and an anti-rabbit secondary antibody (blue labeling), HA-LegK2 on the
LCVs was labeled with an anti-HA antibody and an anti-mouse secondary antibody (red labeling), and actin was stained with phalloidin-FITC (green
labeling). Arrows indicate LegK2-positive LCVs (without actin labeling), and the dotted arrow indicates an LCV without LegK2 on its surface that was
consequently stained for actin. Scale bar, 10 m. This micrograph is representative of 50 LCVs observed in two independent experiments.
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CK-666 partially reverts the legK2 deletion mutant phenotype for
the endocytic pathway evasion defect. Thus, chemical inhibition
of the actin nucleator activity of ARP2/3 phenocopies the effect of
LegK2 protein kinase, which suggests that LegK2 acts on ARP2/3
by inhibiting its normal actin nucleation activity. Together, these
data show that the LegK2-ARP2/3 interplay results in inhibition of
both actin polymerization on the LCV and late endosome traffick-
ing toward the LCV and that these events contribute to bacteria
evasion of the endocytic pathway.
DISCUSSION
Host cell pathways targeted by the Legionella protein kinase LegK2
were screened by a two-hybrid assay in yeast cells, and several
human proteins were identified as putative candidates for inter-
action with LegK2. As the legK2 mutant prevents evasion of en-
docytic degradation (24), we focused our studies on proteins
involved in host cell organelle trafficking and cytoskeleton remod-
eling. Using biochemical and tissue culture assays, we demon-
strated that LegK2 interacts with and phosphorylates the ARP3
and ARPC1B subunits of the actin filament nucleator ARP2/3
complex. These data highlight ARP2/3 phosphorylation as a
mechanism for controlling ARP2/3 complex activity (26–28). Ex-
pression of active LegK2 inhibits host cell invasion and actin
comet tail formation during Listeria infection, i.e., two well-
documented ARP2/3-dependent actin polymerization processes,
while the kinase-dead variant is unable to do so. Thus, we have
robustly demonstrated that LegK2 is a potent inhibitor of the
ARP2/3 complex and that the protein kinase activity of LegK2 is
essential for this property.
During Legionella infection, rather than changing the overall
level of actin polymerization, we observed that LegK2 interferes
with local actin remodeling, most likely by being targeted to the
LCV and inhibiting actin polymerization in this compartment.
This local effect on actin polymerization is ARP2/3 dependent
since it can be phenocopied by a specific chemical inhibitor of the
ARP2/3 complex. Inhibition of actin polymerization on the LCV
is consistent with comparative proteomics of phagosomes con-
taining highly virulent L. pneumophila Corby versus the less viru-
lent species L. hackeliae. These studies revealed that phagosomes
containing nonreplicative L. hackeliae displayed more polymer-
ized actin than those containing the virulent Legionella species
(33). The authors of that study proposed that this change in viru-
lence was due to actin degradation on the LCV containing the
FIG 5 LegK2 inhibits late endosome trafficking to LCVs. (A) Acquisition of
vacuolar proton ATPase on LCVs. D. discoideum was infected for 1 h at an MOI
of 100 with mCherry-labeled legK2 mutant L. pneumophila. The presence of
vacuolar H-ATPase on LCVs was detected by an immunofluorescence assay
with anti-VatA antibodies. The inset shows typical VatA-positive vacuoles. (B)
Acquisition of vacuolar proton ATPase in legK2 mutant-containing vacuoles.
VatA-positive vacuoles (n  100) in amoebae infected with WT L. pneumo-
phila Lens, the derivative dotA and legK2 mutants, and the transformed
legK2(plegK2) and legK2(plegK2cat) mutants were counted. These data are
representative of three independent experiments, and the error bars represent
the standard deviations. **, P  0.01.
FIG 6 ARP2/3 chemical inhibition complements a legK2 gene deletion defect.
(A) Actin polymerization on LCVs in the presence of CK-666. More than 100
LCVs were scored from each sample of phalloidin-FITC-labeled D. discoideum
infected at an MOI of 100 with mCherry-labeled L. pneumophila Lens or the
legK2 mutant in the absence or presence of 100 M CK-666. These data are
representative of three independent experiments, and the error bars represent
the standard deviations. (B) Acquisition of vacuolar proton ATPase on LCVs
in the presence of CK-666. More than 100 LCVs were scored for VatA immu-
nolabeling in each sample of D. discoideum infected at an MOI of 100 with
mCherry-labeled L. pneumophila Lens or the legK2 mutant in the absence or
presence of 100 M CK-666. These data are representative of three indepen-
dent experiments, and the error bars represent the standard deviations. **, P 
0.01.
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virulent L. pneumophila strain, but it also could result from inhi-
bition of actin polymerization on the LCV. Moreover, it is note-
worthy that the ARP2/3 complex, along with other actin
cytoskeleton-associated proteins, is transiently enriched in the
proteome of the nascent Legionella-containing phagosome with-
out any significant changes between virulent and avirulent bacte-
ria (33). These observations are consistent with our finding that
LegK2 could control the activity of the ARP2/3 complex on the
LCV rather than the recruitment of the actin nucleator complex.
Our finding that LegK2 is a key Dot/Icm T4SS effector of the
control of actin polymerization remodeling on the LCV gives im-
portant insights to help understand the molecular mechanisms by
which L. pneumophila evade endocytic degradation. We demon-
strated that LegK2 contributes to L. pneumophila evasion of endo-
some trafficking toward the LCV and that this role is dependent
on the interplay between LegK2 and ARP2/3 to inhibit actin po-
lymerization on the LCV. Although Legionella evasion of the en-
docytic pathway is a main virulence-related event of the infection
cycle of L. pneumophila, the molecular mechanisms involved in
hijacking this pathway are limited to the demonstration that
L. pneumophila secretes SidK, which inhibits V-ATPase activity, to
decrease LCV acidification (18). Here, our results highlight the
essential role of LegK2 activity in the inhibition of actin polymer-
ization on the LCV, thus preventing fusion with late endosomes
and finally rerouting the phagosome to a replicative niche.
Actin polymerization has recently been identified as a host cell
target of two other Dot/Icm substrates, VipA (40) and Ceg14
(Lpg0437) (41). The Legionella VipA effector binds actin in vitro
and directly polymerizes microfilaments without the requirement
of additional proteins, a property distinct from those of other
bacterial actin nucleators. Microscopy studies have revealed that
VipA localizes to actin patches and early endosomes during mac-
rophage infection (40). The Legionella effector Ceg14 cosediments
with filamentous actin and inhibits in vitro actin polymerization.
Ceg14 is toxic to yeast, and this toxicity can be alleviated by over-
expression of the cytoskeleton-related protein profilin. Despite its
molecular effect on actin polymerization, the role of Ceg14 in
Legionella infection is still not documented (41). In future studies,
it will be interesting to decipher whether LegK2, Ceg14, and VipA
display synergic or antagonistic activities to temporally control
actin polymerization on the LCV in order to control LCV biogen-
esis. Interestingly, whatever the precise mechanism controlled by
each of these T4SS effectors, LegK2 function seems to be predom-
inant since a legK2 single mutant is affected in virulence while a
vipA or ceg14 mutant is altered neither for entry nor for replica-
tion in amoebae and macrophages, like most of the Dot/Icm ef-
fector mutants. Noteworthy, an unanswered question is whether
the growth defect of the legk2 mutant is due only to its failure to
inhibit actin nucleation around the phagosome. Nevertheless,
VipA, Ceg14, and LegK2 effectors highlight the host cell actin
cytoskeleton as a major target of Legionella, and we demonstrate
here for the first time that actin remodeling is a critical determi-
nant of an effective cycle of L. pneumophila infection.
Actin cytoskeleton remodeling is known to be targeted by nu-
merous extra- and intracellular bacteria in order to (i) trigger
bacterial uptake by nonphagocytic cells (42), (ii) move within the
host cell cytosol and spread from cell to cell (43), or (iii) decorate
the phagocytic vacuole with a polymerized actin meshwork (44).
To date, actin remodeling targeted by bacteria to alter host cell
organelle trafficking for successful infection, as we propose LegK2
to do, has not been described. Moreover, the ARP2/3 complex has
been shown only to be hijacked by recruiting or mimicking NPFs
but not shown to be modified by phosphorylation to control
ARP2/3-dependent actin nucleation activity. Thus, both the role
of actin remodeling and the molecular mechanism controlled by
the Legionella effector LegK2 are unique and novel.
It is noteworthy that the atypical protein kinase SteC from
Salmonella enterica serovar Typhimurium is required for F-actin
meshwork formation around the Salmonella-containing vacuole
(45). Although SteC has recently been shown to target another
actin cytoskeleton effector protein, namely, the MAP kinase MEK
(46), we note the similarity of both the enzymatic activities of the
bacterial protein kinases LegK2 and SteC to the host cell actin
cytoskeleton remodeling pathway targeted by these kinases. Sim-
ilarly, the Yersinia pseudotuberculosis T3SS effector YpkA is an
essential virulence determinant that disrupts the host actin cyto-
skeleton and inhibits phagocytosis. In the presence of actin, the
kinase YpkA phosphorylates Gq, which impairs guanine nucleo-
tide binding by Gq and results in the inhibition of multiple Gq
signaling pathways, among which are Rho GTPase activation and
consequently actin stress fiber assembly (47). Although the mo-
lecular mechanisms controlled by these protein kinases are differ-
ent in each case, the role of protein phosphorylation in the control
of host cell actin remodeling emerges as a paradigm in bacterial
pathogenesis.
MATERIALS AND METHODS
Cells, bacteria, and plasmids. For the bacterial strains, cells, and plasmids
used in this study, see Table S1 in the supplemental material.
L. pneumophila strains were grown at 30°C either on buffered charcoal
yeast extract (BCYE) agar or in BYE liquid medium. Each medium was
supplemented with 5 g·ml1 chloramphenicol when appropriate.
L. monocytogenes strain EGDe.PrfA* (BUG 3057) was cultured in brain
heart infusion broth at 37°C. Escherichia coli strains were grown at 37°C in
LB medium supplemented with 100 g·ml1 ampicillin, 20 g·ml1
kanamycin, 100 g·ml1 spectinomycin, and 20 g·ml1 chloramphen-
icol. E. coli strains XL1-Blue and DH5 were used to maintain plasmids,
and E. coli strain BL21(DE3)(pREP4-groESL) was used for recombinant
protein overproduction.
S. cerevisiae strains AH109 and Y187 were grown at 30°C in rich YPD
(yeast extract, peptone, dextrose) medium or in SD (synthetic dextrose)
medium supplemented with the appropriate amino acids.
The WT amoeba D. discoideum strain AX2 (DBS0235534) was ob-
tained from the Dicty Stock Center (http://dictybase.org). D. discoideum
cells were grown axenically in HL5 medium at 22°C with 100 g·ml1
streptomycin and 66 g·ml1 penicillin G.
Human HEK293T fibroblasts and human epithelial HeLa cells (gift
from INSERM U1111, Lyon, France) were maintained at 37°C in 5% CO2
in DMEM (Dulbecco’s modified Eagle’s medium) supplemented with
10% heat-inactivated fetal calf serum (FCS) and 50 g·ml1 gentamicin.
HeLa CCL-2 cells (American Type Culture Collection) were cultured at
37°C in DMEM supplemented with 10% heat-inactivated FCS in a 10%
CO2 atmosphere.
General DNA techniques and Gateway cloning. For the oligonucleo-
tides used in this study, see Table S2 in the supplemental material.
DNA constructions were performed with the Gateway recombina-
tional cloning system as recommended by the manufacturer (Invitrogen)
or by restriction-ligation molecular cloning. Plasmid DNA from E. coli
was prepared by Plasmid Midi and Mini kits (Qiagen). PCR amplifica-
tions were carried out with Phusion polymerase as recommended by the
manufacturer (Finnzymes). Site-directed mutagenesis experiments were
performed with the QuikChange II site-directed mutagenesis kit (Strat-
agene). To obtain the kinase-dead mutant protein LegK2K112M defective
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in phosphate donor ATP binding and the kinase-dead mutant protein
LegK2K112M/D209N defective in both phosphate donor ATP binding and
phosphate transfer, nucleotide substitutions in the legK2 gene were per-
formed with primer pairs 1/2 and 3/4 (see Table S2).
Vector construction. The DNA fragments corresponding to the legK1
(lpl1545) and legK2 (lpl2066) coding sequences were PCR amplified by
using genomic DNA of L. pneumophila Lens as the template and oligonu-
cleotide pairs 5/6 and 7/8 (see Table S2), respectively. The coding se-
quences were inserted into the Gateway pDONR207 vector (Invitrogen)
by in vitro recombination. The LegK1- and LegK2-encoding genes were
then transferred from pDONR207 to pGBKT7 (Clontech), thus produc-
ing LegK proteins fused to the DNA binding domain of the GAL4 tran-
scriptional activator in yeast cells. The LegK2-encoding gene was also
transferred by Gateway cloning from pDONR207-legK2 to vectors pD-
EST27 and peGFP (Invitrogen) to produce GST-tagged LegK2 and
N-terminally GFP-fused LegK2 proteins in mammalian cells, respectively.
The legK2 gene from pXDC61-legK2 (gift from J. Allombert in our lab)
was ligated into plasmid pMMB207c-HA*4 at the BamHI and KpnI re-
striction sites (gift from G. Frankel, London, United Kingdom [48]) to
encode N-terminally HA-tagged LegK2 upon isopropyl--D-
thiogalactopyranoside (IPTG) induction in L. pneumophila cells. The mu-
tated legK2K112M/D209N gene was ligated into the SphI restriction site of
pXDC50 to encode kinase-dead LegK2 under the control of its own pro-
moter in L. pneumophila cells.
ARPC1B and ACTR3 cDNAs were obtained from the human OR-
Feome resource (hORFeome v3.1) in the pDONR223 Gateway vector.
cDNAs were transferred by in vitro recombination from pDONR into
yeast vector pACT2 (Clontech) to produce proteins fused with the tran-
scription activator domain of GAL4. ARPC1B and ACTR3 cDNAs were in
vitro recombined from pDONR223 vectors to the pCI-Neo3Flag vector
(Invitrogen), thus producing 3Flag-tagged ARP2/3 complex subunits in
mammalian cells.
Yeast two-hybrid screening and binary assays. Vectors pGBKT7-
legK1 and -legK2, which encode LegK proteins fused to the DNA binding
domain of the GAL4 transcriptional activator, were transformed into bait
yeast strain AH109. Bait cells were screened against a human normalized
cDNA spleen library for systematic screening or against ACTR3 and
ARPC1B for binary assays cloned into vector pACT2 transformed into
prey yeast strain Y187, which produces human proteins fused to the tran-
scriptional activator domain of GAL4. AH109(pGBKT7-legK) and
Y187(pACT2-human cDNA), Y187(pACT2-ACTR3), or Y187(pACT2-
ARPC1B) yeast cells were mated and subsequently plated onto a selective
medium lacking histidine and supplemented with 10 mM 3AT to test the
interaction-dependent transactivation of the HIS3 reporter gene.
Affinity copurification. HEK293T cells were cotransfected with pD-
EST27, pDEST27-legK2, or pDEST27-legK2K112M and pCI-Neo3Flag-
ARPC1B or -ACTR3 by using Lipofectamine 2000 (Invitrogen). Trans-
fected cells were lysed at 24 h posttransfection in modified RIPA buffer
(50 mM Tris HCl [pH 7.4], 100 mM NaCl, 10% glycerol, 1% NP-40), and
GST-tagged LegK2 or LegK2K112M was purified on glutathione-agarose
4B (Macherey-Nagel). Purified fractions were immunoblotted with both
anti-GST (13-6700; Invitrogen) and anti-Flag (clone M2; Sigma) antibod-
ies to detect GST or GST-tagged LegK2 protein and Flag-tagged ARP2/3
subunits, respectively.
Protein localization in transfected mammalian cells. HEK293T cells
were transfected or cotransfected with empty pDEST27 or pDEST27-
legK2/legK1 and/or pCI-Neo3Flag-ARPC1B/ACTR3 by using Lipo-
fectamine 2000 (Invitrogen). At 24 h posttransfection, cells were fixed
with 3.7% formaldehyde and permeabilized with 0.1% Triton X-100.
Flag-tagged ARPC1B and ARP3 proteins were immunolabeled with
mouse anti-Flag antibodies conjugated with the fluorochrome Cy3
(A9594; Sigma). GST, GST-LegK2, or GST-LegK1 protein was labeled
with a rabbit anti-GST antibody (A7340; Sigma) and detected with an
anti-rabbit secondary antibody conjugated with the fluorochrome Alexa
Fluor 488 (A11034; Molecular Probes). Microscopy was carried out with a
confocal laser scanning microscope (LSM510 Meta; Zeiss). Quantitation
of images was performed with ImageJ software (National Institutes of
Health). The Pearson coefficient was determined with a JACoP plugin
(49) and expressed as the mean value calculated for 30 cells.
ARP2/3 complex in vitro phosphorylation assays. GST-LegK2 and
GST-LegK2K112M were overproduced in and purified from E. coli as pre-
viously described (24). The ARP2/3 complex was purified from A. castel-
lanii as previously described (26, 50). Where indicated, ARP2/3 was de-
phosphorylated with the dual-specificity Antarctic phosphatase (New
England Biolabs Inc.) as previously described (26). In vitro phosphoryla-
tion of 7.2 g of the purified ARP2/3 complex was performed in the
presence of 1 g of GST-LegK2 or GST-LegK2K112M for 30 min at 37°C in
20 l of a buffer containing 25 mM Tris HCl (pH 7.5), 5 mM MnCl2,
5 mM dithiothreitol, and 100 mM ATP. Reactions were stopped by the
addition of an equal volume of 2 Laemmli loading buffer (51). Where
indicated, the reaction was further incubated in the presence of 10 U of
Antarctic phosphatase for 1 h at 30°C before the addition of Laemmli
buffer. Proteins were then separated by SDS-PAGE and immunoblotted
with an antiphosphothreonine monoclonal antibody (clone PTR-8;
Sigma).
ARPC1B and ARP3 in cellulo phosphorylation assays. HEK293T
cells were transfected or cotransfected with vectors pCI-Neo3Flag-
ARPC1B/ACTR3 and pDEST27-legK2 or -legK2K112M by using Lipo-
fectamine 2000 (Invitrogen). Protein A/G resin was cross-linked with
10 g of anti-Flag antibodies by using a Pierce Cross-link immunopre-
cipitation kit (Thermo Scientific). Transfected cells were lysed at 24 h
posttransfection, and Flag-tagged ARP2/3 subunits were immunoprecipi-
tated as recommended by the manufacturer. Immunoprecipitation su-
pernatants were then incubated with glutathione-agarose 4B (Macherey-
Nagel) and analyzed by Western blot assay with anti-GST antibodies to
check the expression of the GST-tagged LegK2 and LegK2K112M protein
kinases. Immunoprecipitated proteins were immunoblotted with both
anti-Flag (clone M2; Sigma) and antiphosphothreonine (clone PTR-8;
Sigma) antibodies to check the immunoprecipitation and phosphoryla-
tion level of the ARP2/3 subunits, respectively.
In vitro actin polymerization assays. In vitro actin polymerization
assays were performed with 5 M monomeric actin containing 10%
pyrene-labeled actin in KMEI (50 mM KCl, 1 mM MgCl2, 1 mM EGTA,
10 mM imidazole [pH 7.0]). Polymerization was determined in the ab-
sence or presence of the ARP2/3 complex at 50 nM, the VCA domain of
N-WASP at 500 nM, and recombinant WT LegK2. Fluorescence was mea-
sured with a BioTek Synergy 2 plate reader with 365-nm excitation and
407-nm emission filters at 10-s intervals. The purified ARP2/3 complex
was dephosphorylated by treatment with 1 U of Antarctic phosphatase
(New England Biolabs, Inc., Ipswich, MA) in Tris-HipH buffer (50 mM
Tris [pH 8.0], 1 mM MgCl2, 0.1 mM ZnCl2) for 1 h at 30°C. The activation
and inhibition of the ARP2/3 complex by LegK2 were tested on the de-
phosphorylated and phosphorylated ARP2/3 complex, respectively.
Actin polymerization in transfected mammalian cells. HeLa cells
were transfected with Lipofectamine 2000 (Invitrogen) according to the
manufacturer’s instructions with a vector encoding peGFP alone or fused
with legK2 or legK2K112M. At 24 h posttransfection, cells were fixed with
4% paraformaldehyde, permeabilized with 0.1% Triton X-100 for 5 min
at room temperature (RT), and stained with Alexa Fluor 594 phalloidin
(Molecular Probes). Microscopy was carried out with a confocal laser
scanning microscope (LSM510 Meta; Zeiss).
Listeria comet actin tail formation. HeLa CCL-2 cells grown on cov-
erslips were transfected for 18 h with the empty vector peGFP or with the
peGFP-legK2 vector with the FuGENE transfection reagent (Roche) at a
ratio of 2 g of DNA to 6 l of FuGENE per treatment. Bacteria were
grown overnight at 37°C in a shaking device, and on the following day,
1 ml of bacterial culture was washed three times with 1 ml of phosphate-
buffered saline (PBS) and the optical density at 600 nm was measured to
estimate bacterial numbers. HeLa cells were infected at a multiplicity of
infection (MOI) of 5 for 1 h in DMEM supplemented with 1% FCS, and
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then extracellular bacteria were killed by adding DMEM supplemented
with 10% FCS and gentamicin at 10 g·ml1. After 5 h of infection, HeLa
cells were fixed with 4% paraformaldehyde and extracellular L. monocy-
togenes bacteria were labeled by adding a rabbit-derived polyclonal serum
(R11) and an Alexa Fluor 647-conjugated secondary antibody (Molecular
Probes). Cells were then permeabilized for 4 min with 0.1% Triton X-100
in PBS, and total bacteria were labeled with the same R11 serum and an
Alexa Fluor 350-conjugated secondary antibody (Molecular Probes). Ac-
tin was labeled with phalloidin Alexa Fluor 546-coupled reagent (Molec-
ular Probes). Images were acquired with a 100 objective installed on an
inverted wide-field Axiovert 200M microscope (Zeiss) equipped with an
electron multiplication charge-coupled device Neo camera (Andor) and
the MetaMorph imaging software (Molecular Devices).
D. discoideum infection by L. pneumophila for microscopic analy-
sis. D. discoideum cells were seeded onto sterile glass in MB (7.15 g · liter1
yeast extract, 14.3 g · liter1 peptone, 20 mM MES [pH 6.9]). Monolayers
were infected at an MOI of 100 with bacteria grown for 4 days at 30°C. The
plates were spun at 880  g for 10 min and further treated for microscopic
analysis.
LegK2 protein localization during infection. D. discoideum cells were
seeded onto sterile glass coverslips in MB. The L. pneumophila dotA or
legK2 mutant strain encoding N-terminally HA-tagged LegK2 protein
was grown for 21 h at 37°C. Two hours before use, HA-tagged LegK2
protein production was induced by the addition of 2 mM IPTG. Mono-
layers were infected at an MOI of 100. The plates were spun at 880  g for
10 min, and cells were immediately fixed or incubated for 5, 10, 15, 20, 30,
or 60 min at 25°C. Monolayers were fixed with 4% paraformaldehyde and
permeabilized with 100% ice-cold methanol. The coverslips were then
stained with anti-HA antibodies (3724S; Cell Signaling) and visualized
with an Alexa Fluor 488-conjugated secondary antibody (A11034; Molec-
ular Probes). Bacteria were immunolabeled with a rhodamine-conjugated
anti-MOMP antibody (52). Microscopy was carried out with a confocal
laser scanning microscope (LSM510 Meta; Zeiss).
Actin polymerization in infected cells. D. discoideum on sterile glass
coverslips was infected with Legionella as described above in the absence
or presence of 100 M CK-666, and cells were immediately fixed or incu-
bated for 15 min at 25°C. Monolayers were fixed with 4% paraformalde-
hyde and permeabilized with 0.1% Triton X-100 for 5 min at RT. The
coverslips were then stained with phalloidin-FITC (P5282; Sigma). Mi-
croscopy was carried out with a confocal laser scanning microscope
(LSM510 Meta; Zeiss).
Detection of LegK2 and actin on LCVs. .D. discoideum on sterile glass
coverslips was infected with Legionella as described above, and cells were
incubated for 15 min at 25°C. Monolayers were fixed with 4% parafor-
maldehyde and permeabilized with 0.1% Triton X-100 for 5 min at RT.
The coverslips were then stained with mouse anti-HA antibodies (gift
from S. Salcedo, Lyon, France) and visualized with a Dylight 594 (115-
515-003; Jackson)-conjugated secondary antibody. Bacteria were immu-
nolabeled with anti-Lp1 Paris/Lens strain serum and an Alexa Fluor 547-
conjugated anti-rabbit secondary antibody (A21245; Molecular Probes),
and actin was stained with phalloidin-FITC (P5282; Sigma). Microscopy
was carried out with a confocal laser scanning microscope (LSM510 Meta;
Zeiss).
Maturation of Legionella-containing phagosomes. D. discoideum on
sterile glass coverslips was infected with Legionella as described above.
CK-666 (100 M) was added 5 min after amoeba-Legionella contact, and
plates were incubated for 1 h at 25°C. Monolayers were fixed with 4%
paraformaldehyde, permeabilized with 100% ice-cold methanol for 2 min
at RT. The coverslips were then stained with anti-VatA antibodies (221-
35-2; gift of F. Letourneur, Lyon, France) and visualized with an Alexa
Fluor 488-conjugated secondary antibody (A11029; Molecular Probes).
Microscopy was carried out with a confocal laser scanning microscope
(LSM510 Meta; Zeiss).
Statistical analysis. The results were statistically analyzed with Stu-
dent’s t test. The results obtained correspond to a comparison of the
values obtained with the legK2 mutant and those obtained with the pa-
rental strain under the same conditions or of the values obtained in the
absence or presence of CK-666, the ARP2/3 complex inhibitor.
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